Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux(NERD) Disease: Double-blind, Randomized

NCT07160790 is registered in ClinicalTrials.gov with Onconic Therapeutics Inc. as lead sponsor.

NCT NCT07160790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07160790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux(NERD) Disease: Double-blind, Randomized
Lead sponsor
Onconic Therapeutics Inc.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 2, 2025
Completion date
June 30, 2026
Enrollment
321 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-erosive gastroesophageal reflux disease